Clinical Trial Update: A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a GLP-1 receptor agonist plus metformin for diabetes remission in overweight or obese adults newly diagnosed with Type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucagon-like peptide-1 receptor agonist
• metformin (metformin)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: UNKNOWN